Home Online Features Lumicell Announces Promising Feasibility Trial Findings Using Pegulicianine in Gastrointestinal Cancer Patients
Lumicell Announces Promising Feasibility Trial Findings Using Pegulicianine in Gastrointestinal Cancer Patients
Hand-out
Press Releases
April 28, 2025

Lumicell Announces Promising Feasibility Trial Findings Using Pegulicianine in Gastrointestinal Cancer Patients

By Lumicell, Inc.

Pioneering real-time detection of cancer brings promise to enabling a more complete resection in gastrointestinal cancer surgery

bradford

The Bradford Era

email
Local & Social